- Home
- CTXR vs AVAT Comparison
CTXR vs AVAT Comparison
Compare CTXR & AVAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTXR | AVAT |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.7M | 21.3M |
| IPO Year | 2010 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CTXR | AVAT |
|---|---|---|
| Price | $0.74 | $0.36 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 749.6K | 248.2K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.38 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $147.57 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.47 | $0.29 |
| 52 Week High | $2.19 | $0.94 |
Technical Indicators
Market Signals| Indicator | CTXR | AVAT |
|---|---|---|
| Relative Strength Index (RSI) | 61.42 | 36.92 |
| Support Level | $0.68 | $0.29 |
| Resistance Level | $0.74 | $0.37 |
| Average True Range (ATR) | 0.08 | 0.04 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 72.82 | 88.22 |
Price Performance
Historical ComparisonAbout CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
About AVAT Avalanche Treasury Corporation Class A Common Stock
Avalanche Treasury Corp is a digital asset treasury company.